CTNNB1 and craniopharyngioma: Although our WES methodology was limited in its ability to determine whether the 2 stop codon APC mutations occurred on separate alleles, immunohistochemical staining for beta-catenin demonstrated pathologic nuclear localization, characteristic of beta-catenin overexpression and seen in CTNNB1-mutated craniopharyngiomas.